Saamya Biotech IPO which is open for subscription with 15 lakh shares of Rs 10 each to raise around Rs 15 crore. Subscription of Saamya Biotech IPO will close on September 28, 2007.
Majority of experts said to apply for the IPO as they believe that Saamya Biotech has been issued at a reasonable price and the profile of the company is clean considering its directors. People should subscribe with long term view in this IPO.
Experts said that Finchimica, Spa Italy has 100% buying agreement with Saamya Biotech for anti-cancer drug which would be a fetching point for this company on the long term.
Some Analysts have expressed their opinion in not to invest in this IPO as the financial performance of this company is not great and in the post paid capital of the company the promoters stake would be only 7%.
Considering the size of the issue and financing pattern of the project investment is not advised in this IPO.
Based on the above opinions you can give a miss to this IPO, if you are an agressive investor you can invest keeping in view the current market conditions where what ever IPO comes for listing is giving bumper gains.
If you need more information regarding the Saamya Biotech IPO click here.
0 comments ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment